Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7453 p598
26 May 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


GPs report a lack of PCT support for commissioning

Maigi/Dreamstime.com

Excessive bureaucracy

Excessive bureaucracy is a barrier to commissioning

GPs are committed to making practice-based commissioning work but believe that they lack support from primary care trusts, according to a survey of 257 GPs and practice managers carried out by the King's Fund and the NHS Alliance.

Although 73 per cent indicated they are firmly committed to the policy, 39 per cent reported a lack of support from their PCT and 23 per cent believe financial constraints and short-term thinking are preventing implementation. Excessive bureaucracy, meeting national targets and the turmoil of restructuring were also cited as barriers.

The survey findings are published in a report “Practice-based commissioning: from good idea to effective practice”, which makes several recommendations to ensure consistent implementation of PBC. These include that PCTs should establish an “innovation risk fund” that can be called upon to underwrite the risk of innovative PBC plans that might otherwise be put on hold in a risk-averse environment.

Commenting on the report, Georgina Craig, lead for commissioning policy at the Company Chemists’ Association, said: “It should come as no surprise that general practice is embracing PBC. It places practices right at the heart of decision-making on the future development of primary care and, as the main provider of primary care services, that is exactly where GPs want to be.”

She added that the report is uncritical of PBC in its current form, whereas the CCA believes that PBC would be more robust if the inherent conflict of interest between practices’ provider and commissioning functions were addressed and if it became a more collaborative process that ensures engagement with the wider primary care team.

“Gordon Brown is looking for ways of increasing value for money in primary care; he would do well to put PBC policy under the spotlight,” she added.


Agenda for 2007 p611

Back to Top


©The Pharmaceutical Journal